← Back to Clinical Trials
Recruiting NCT07409012

NCT07409012 Development of a Patient-Centered Assessment Tool for Pain During Cesarean Delivery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07409012
Status Recruiting
Phase
Sponsor University Hospital, Basel, Switzerland
Condition Elective Cesarean Delivery
Study Type OBSERVATIONAL
Enrollment 15 participants
Start Date 2026-05
Primary Completion 2026-07

Trial Parameters

Condition Elective Cesarean Delivery
Sponsor University Hospital, Basel, Switzerland
Study Type OBSERVATIONAL
Phase N/A
Enrollment 15
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2026-05
Completion 2026-07

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to develop a standardized tool to assess intraoperative pain during cesarean delivery under neuroaxial anesthesia. The tool will draw on existing scientific literature, expert clinical opinion and the experiences of patients who have recently undergone caesarean delivery. Experts from multiple disciplines will participate in a structured consensus process (Delphi process) to identify and refine key assessment items. Patient interviews will be conducted to ensure that the tool reflects patient priorities and experiences.

Eligibility Criteria

Inclusion Criteria: * Signed informed consent * Age \> 18 years * Proficient in German or Swiss German * Elective cesarean delivery under neuraxial anesthesia in last 48-72 hours * Delivery of an healthy infant of at least 35+1 weeks of gestation Exclusion Criteria: * Known fetal abnormalities or neonatal death * Admission of the neonate to the ICU * Severe postpartum hemorrhage of \>1000ml blood loss * Preeclampsia * Current psychiatric disease, e.g. schizophrenia, personality disorders * Substance abuse * Chronic pain disease

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology